83 filings
Page 4 of 5
8-K
6fr4 4ebvofu2
16 Mar 20
AVROBIO Reports Fourth Quarter and Fiscal Year 2019 Financial Results and Provides Business Update
7:11am
8-K
d5eu d12g
13 Feb 20
AVROBIO Announces Proposed Public Offering of Common Stock
4:14pm
8-K
lcve6mu9c z85zyfw5eq
10 Feb 20
Other Events
4:09pm
8-K
lmgnxc
13 Jan 20
Regulation FD Disclosure
7:01am
8-K
akbvr5nc 9s
7 Nov 19
AVROBIO, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update
7:05am
8-K
kgy3c
7 Oct 19
Regulation FD Disclosure
8:00am
8-K
1mes 5bt0d5k6nnp
8 Aug 19
AVROBIO Reports Second Quarter 2019 Financial Results
7:04am
8-K
lh3wd42x
17 Jul 19
AVROBIO Announces Proposed Public Offering of Common Stock
5:23pm
8-K
4qpe9 1o4bej7
15 Jul 19
Other Events
7:07am
8-K
tcdft remw
12 Jun 19
Submission of Matters to a Vote of Security Holders
7:35am
8-K
1blhk m0f6zk
13 May 19
AVROBIO, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update
7:06am
8-K
lammhtq6kn
29 Apr 19
Other Events
7:18am
8-K
94vbr owdvezrpse04c
25 Mar 19
AVROBIO, Inc. Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Provides Business Update
7:16am
8-K
4tef4r ksu6baoak
6 Feb 19
Other Events
9:11am
8-K
so101
22 Jan 19
Other Events
8:00am
8-K/A
u0tcc
11 Jan 19
Departure of Directors or Certain Officers
4:23pm
8-K
r3arozm t9vjkq
7 Jan 19
AVROBIO, Inc. Appoints Philip J. Vickers to its Board of Directors
4:56pm
8-K
nkcc l1r5
21 Dec 18
AVROBIO, Inc. Expands and Strengthens Leadership Team with Four Senior Management Hires
4:19pm
8-K
vx4xcl1
13 Nov 18
AVROBIO, Inc. Reports Third Quarter 2018 Financial Results and Provides Business Update
8:17am
8-K
all9zxwglh d5
1 Oct 18
AVROBIO Announces Updated Clinical Data forAVR-RD-01 Gene Therapy
12:00am